Brokerages Set Surgery Partners, Inc. (NASDAQ:SGRY) Price Target at $27.11

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have earned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $27.1111.

Several research firms recently weighed in on SGRY. Royal Bank Of Canada dropped their target price on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a report on Tuesday, November 11th. JPMorgan Chase & Co. dropped their price objective on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating for the company in a research note on Monday, November 24th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Surgery Partners in a report on Monday, December 29th. Barclays lowered their target price on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating for the company in a report on Friday, November 21st. Finally, UBS Group dropped their target price on Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, November 13th.

Surgery Partners Stock Up 2.2%

Shares of SGRY opened at $16.14 on Friday. The company’s 50-day moving average price is $16.01 and its 200 day moving average price is $19.69. Surgery Partners has a 12-month low of $14.94 and a 12-month high of $26.16. The company has a current ratio of 1.88, a quick ratio of 1.72 and a debt-to-equity ratio of 1.10. The firm has a market cap of $2.09 billion, a P/E ratio of -11.87 and a beta of 1.91.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Monday, November 10th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06). The company had revenue of $821.50 million for the quarter, compared to analysts’ expectations of $823.55 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 5.21%.The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period last year, the business earned $0.19 EPS. On average, sell-side analysts forecast that Surgery Partners will post 0.67 earnings per share for the current year.

Hedge Funds Weigh In On Surgery Partners

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Jones Financial Companies Lllp increased its position in shares of Surgery Partners by 313.1% during the third quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock worth $27,000 after acquiring an additional 930 shares during the period. AlphaQuest LLC grew its stake in Surgery Partners by 94.4% during the 2nd quarter. AlphaQuest LLC now owns 2,057 shares of the company’s stock worth $46,000 after purchasing an additional 999 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its stake in Surgery Partners by 45,640.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock worth $49,000 after purchasing an additional 2,282 shares in the last quarter. PNC Financial Services Group Inc. increased its holdings in Surgery Partners by 128.4% during the 3rd quarter. PNC Financial Services Group Inc. now owns 2,702 shares of the company’s stock worth $58,000 after purchasing an additional 1,519 shares during the period. Finally, FNY Investment Advisers LLC acquired a new stake in Surgery Partners in the 2nd quarter valued at about $115,000.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.